Patent US3853993A successfully refreshed from Google Patents.
US3853993A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for increasing oxygen diffusivity and method for treating atherosclerosis
Assignee: University of Virginia
•
Filing: 1973-06-28
•
Granted: 1974-12-10
•
Expires: 1993-06-28
Abstract
Abstract Diffusivity of oxygen in aqueous solutions has been increased by the introduction of a water soluble carotenoid into the solutions. Carotenoids have been found to be useful for increasing the diffusivity of oxygen in the blood, and hence are useful for the reduction of local hypoxia, which is believed to be one of the factors in development of atherosclerosis. The administration of these materials has resulted in reducing the incidence of atherosclerosis in mammals.
Inventors
- 👤 J Gainer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:38
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61K31/21; A61K31/215; A61K31/70
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
24 words
A METHOD FOR THE TREATMENT OF ATHEROSCLEROSIS IN A MAMMAL WHICH COMPRISES ADMINISTERING TO SAID MAMMALS AN EFFECTIVE DOSE OF A WATER SOLUBLE CAROTENOID.
Claim 2
Independent Claim
24 words
A METHOD FOR THE TREATMENT OF ATHEROSCLEROSIS IN A MAMMAL WHICH COMPRISES ADMINISTERING TO SAID MAMMALS AN EFFECTIVE DOSE OF A WATER SOLUBLE CAROTENOID.
Claim 3
Dependent Claim
13 words
The method of claim 1 wherein said water soluble carotenoid has the formula
Claim 4
Dependent Claim
12 words
The method of claim 2 wherein said water soluble carotenoid is crocin.
Claim 5
Dependent Claim
12 words
The method of claim 2 wherein said water soluble carotenoid is crocetin.
Claim 6
Dependent Claim
32 words
The method of claim 1 wherein said water soluble carotenoid is administered in a dose rate of from 0.005 mg to 100 mg active ingredient per kg of body weight per week.
Claim 7
Independent Claim
50 words
A method for the treatment of atherosclerosis in a mammal which comprises administering to said mammal an amount of a water soluble carotenoid sufficient to increase the diffusivity of oxygen in the blood of said mammal and thereby reduce local hypoxia at the blood tissue interface of the blood vessels.
Claim 8
Independent Claim
50 words
A method for the treatment of atherosclerosis in a mammal which comprises administering to said mammal an amount of a water soluble carotenoid sufficient to increase the diffusivity of oxygen in the blood of said mammal and thereby reduce local hypoxia at the blood tissue interface of the blood vessels.
Claim 9
Dependent Claim
13 words
The method of claim 6 wherein said water soluble carotenoid has the formula
Claim 10
Dependent Claim
12 words
The method of claim 6 wherein said water soluble carotenoid is crocin.
Claim 11
Dependent Claim
12 words
The method of claim 6 wherein said water soluble carotenoid is crocetin.
Claim 12
Dependent Claim
32 words
The method of claim 6 wherein said water soluble carotenoid is administered in a dose rate of from 0.005 mg to 100 mg active ingredient per kg of body weight per week.
Claim 13
Independent Claim
48 words
A method for the treatment of atherosclerosis in a mammal which comprises administering a water soluble cartenoid in a dose rate of from 0.005 mg to 100 mg active ingredient per kg of body weight per week to said mammal, wherein said water soluble cartenoid has the formula:
Claim 14
Independent Claim
48 words
A method for the treatment of atherosclerosis in a mammal which comprises administering a water soluble cartenoid in a dose rate of from 0.005 mg to 100 mg active ingredient per kg of body weight per week to said mammal, wherein said water soluble cartenoid has the formula:
Claim 15
Independent Claim
56 words
A method for reducing the quantity of cholesterol, phospholipids and triglycerides in the blood serum of a mammal, which comprises administering a water soluble cartenoid in a dose rate of from 0.005 mg to 100 mg active ingredient per kilogram of body weight per week, to said mammal, wherein said water soluble cartenoid has the formula
Claim 16
Independent Claim
56 words
A method for reducing the quantity of cholesterol, phospholipids and triglycerides in the blood serum of a mammal, which comprises administering a water soluble cartenoid in a dose rate of from 0.005 mg to 100 mg active ingredient per kilogram of body weight per week, to said mammal, wherein said water soluble cartenoid has the formula
Claim 17
Dependent Claim
12 words
The method of claim 12, wherein said water soluble cartenoid is crocin.
Claim 18
Dependent Claim
11 words
The method of claim 12, wherein said water-soluble cartenoid is crocetin.
Claim 19
Dependent Claim
51 words
The method of claim 12, wherein each R'' is hydrogen or methyl and each R is a hydrophilic group selected from the group consisting of carboxyl groups or ester groups of the form COOR'''', wherein R'''' represents a soluble sugar group, an alkanol group, carboxy substituted lower alkyl, hydroxyl or amine.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1977-12-09 | 1978-06-10 | 1978-12-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1981-12-09 | 1982-06-10 | 1982-12-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1985-12-09 | 1986-06-10 | 1986-12-10 | $7700.00 | Window Closed / Lapsed |